Premier ERISA Law Firm Solidifies Its Litigation Practice

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Premier ERISA Law Firm Solidifies Its Litigation Practice With the Appointment of Stephen D. Rosenberg as Partner

BOSTON, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Marcia Wagner, the Managing Director of The Wagner Law Group, amongst the country’s top ERISA and employee benefits law firms, is pleased to announce that Stephen D. Rosenberg , one of the firm’s outstanding litigation attorneys, has been appointed as a partner to the firm, effective as of January 1, 2016. “ Steve has raised the bar for the growing ERISA litigation practice within our firm as an elite attorney in the ERISA litigation world, and it is an honor for us to name him a partner, ” says Ms. Wagner.

Stephen Rosenberg is a seasoned ERISA and business disputes lawyer, with substantial expertise in ERISA litigation, ERISA governed benefit plans, fiduciary obligations, plan regulation, ESOPs, top-hat plans, and class actions and has first chair trial experience in federal courts, state courts and commercial arbitrations.  In addition, Mr. Rosenberg has extensive experience counseling clients on and litigating executive compensation, copyright infringement, software dispute, director and officer, class action, insurer bad faith, reinsurance, complex insurance coverage, construction, business dispute and patent cases.  Mr. Rosenberg is also a widely published author and is the author of the highly respected “Boston ERISA & Insurance Litigation Blog.”  Mr. Rosenberg is a crucial part of the Wagner Law Group’s litigation team and has increased both the firm’s breadth and depth in its growing litigation practice.

The Wagner Law Group is also pleased to announce the appointment of Caroline M. Fiore  to the position of Senior Associate.  Ms. Fiore is an accomplished commercial and regulatory lawyer with extensive experience in appellate litigation, administrative law, commercial litigation, insurance, class action, Chapter 93A, employee benefit and ERISA disputes.

The Wagner Law Group : Since its establishment in 1996, The Wagner Law Group has been dedicated to the highest standards of integrity, excellence and thought leadership and is considered to be amongst the nation’s most exceptional ERISA and employee benefits law firms.  The firm has five offices – Boston, San Francisco, Tampa, Palm Beach Gardens and St. Louis, providing unparalleled legal advice to its clients, including large, small and nonprofit corporations as well as individuals and government entities, in over 45 states and several foreign countries. The Wagner Law Group’s 23 attorneys, a senior benefits consultant and four paralegals combine many years of experience in their specialty fields of practice with a variety of backgrounds. Six of the attorneys are AV rated by Martindale-Hubbell as having very high to preeminent legal abilities and ethical standards. Six attorneys have been named to the prestigious Super Lawyers lists, which highlight outstanding lawyers based on a rigorous selection process.

FOR MORE INFORMATION, CONTACT: Ari J. Sonneberg asonneberg@wagnerlawgroup.com (617) 357-5200

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 19

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 24

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 30

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 18

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 23

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 25

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

Alterity Therapeutics Showcases Innovation at Healthcare Event

Updated Category News Views 142

Alterity Therapeutics to Present at a Virtual Healthcare Conference Alterity Therapeutics, a biotechnology firm dedicated to developing treatments for neurodegenerative diseases, has recently announced its participation in an upcoming healthcare virtual conference. The event will shine a spotlight on influential healthcare companies and their innovative approaches to...

Continue Reading
Important Update for Toronto-Dominion Bank Investors on Lawsuit

Updated Category News Views 58

Update for Investors in Toronto-Dominion Bank Kahn Swick & Foti, LLC, led by the experienced former Louisiana Attorney General Charles C. Foti, Jr., is reminding investors that significant changes are arriving for shareholders of Toronto-Dominion Bank (NYSE: TD). As the legal landscape evolves, those who experienced losses may want to take immediate action regarding their...

Continue Reading
GCC's Quarterly Performance Analysis: Key Insights Revealed

Updated Category News Views 221

GCC Reports Significant First Quarter Financials GCC, S.A.B. de C.V. (BMV: GCC*), recognized as a premier supplier and producer of cement, concrete, and aggregates, has shared its financial results for the first quarter. Despite facing various challenges, GCC's performance metrics reveal a resilience that is noteworthy. Q1 2025 Highlights In the first quarter of 2025, GCC...

Continue Reading
Indonesia's IDX Composite Index Declines Amid Market Pressures

Updated Category News Views 116

Overview of Recent Market Movements in Indonesia Indonesia's stock market experienced a downturn at the close of trading, influenced by various sectors showing significant losses. The IDX Composite Index reflected a decrease of 0.98%, marking a notable dip to a one-month low. This downturn is primarily attributed to declines in several key sectors, including...

Continue Reading
Blink Charging Achieves Advanced Certification for EV Chargers

Updated Category News Views 130

Blink Charging Receives Prestigious OCPP 2.0.1 Certification Blink stands out as one of just five EV charging companies in the U.S. to earn this coveted certification. Bowie, Md. – Blink Charging Co. (NASDAQ: BLNK), a prominent name in electric vehicle (EV) charging equipment and services, has proudly announced that its Series 7, 8, and 9 charger models have...

Continue Reading